Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 8;8(1):7281.
doi: 10.1038/s41598-018-25645-9.

Tortuous Pore Path Through the Glaucomatous Lamina Cribrosa

Affiliations

Tortuous Pore Path Through the Glaucomatous Lamina Cribrosa

Bo Wang et al. Sci Rep. .

Abstract

The lamina cribrosa is a primary site of damage in glaucoma. While mechanical distortion is hypothesized to cause reduction of axoplasmic flow, little is known about how the pores, which contains the retinal ganglion cell axons, traverse the lamina cribrosa. We investigated lamina cribrosa pore paths in vivo to quantify differences in tortuosity of pore paths between healthy and glaucomatous eyes. We imaged 16 healthy, 23 glaucoma suspect and 48 glaucomatous eyes from 70 subjects using a swept source optical coherence tomography system. The lamina cribrosa pores were automatically segmented using a previously described segmentation algorithm. Individual pore paths were automatically tracked through the depth of the lamina cribrosa using custom software. Pore path convergence to the optic nerve center and tortuosity was quantified for each eye. We found that lamina cribrosa pore pathways traverse the lamina cribrosa closer to the optic nerve center along the depth of the lamina cribrosa regardless of disease severity or diagnostic category. In addition, pores of glaucoma eyes take a more tortuous path through the lamina cribrosa compared to those of healthy eyes, suggesting a potential mechanism for reduction of axoplasmic flow in glaucoma.

PubMed Disclaimer

Conflict of interest statement

Dr. Schuman and Dr. Fujimoto receive royalties for intellectual property licensed by Massachusetts Institute of Technology and Massachusetts Eye and Ear Infirmary to Zeiss.

Figures

Figure 1
Figure 1
Pore path tracing. (A) Enface view of the lamina cribrosa. (B) Pore paths were traced with respect to depth via the centroid of the segmented pores. (C) 3D view of pore path tracing from a subset of pores in a single eye (27 out of 81).
Figure 2
Figure 2
Identification of pore path relative to the disc. (A) Method of identification of pore path relative to the central disc (dotted red line). Positive distance change (path 1; blue) indicated convergence towards the center, while negative distance change (path 2; green) indicated convergence away from the center. (B) Example of LC identified to have pores going towards the disc center (red dotted line) and (C) away from disc center.
Figure 3
Figure 3
Assessment of pore path relative to disc. (A) Schematic demonstration of examples of negative path change (pores move away from disc center going from anterior to posterior) and positive path change (pores move towards the disc center). (B) Boxplot of pore path change with respect to diagnosis (H – healthy, GS – glaucoma suspect, GL – glaucomatous eyes) and (C) visual field mean deviation.
Figure 4
Figure 4
Assessment of pore tortuosity. (A) Pore tortuosity was defined by dividing the distance traveled by the pore centroid (yellow line) by the shortest distance between the top and bottom pore (purple line). (B) Schematic showing examples of low tortuosity (green) and high tortuosity (red). (C) Boxplot of tortuosity as a function of diagnosis (H – healthy, GS – glaucoma suspect, GL – glaucomatous eyes). (D) Probability density distribution of pore tortuosity as a function of disease (Green – healthy, Blue – glaucoma suspect, Red – glaucomatous eyes). (E) Pore tortuosity as a function of visual field mean deviation, with the green lines denoting the 95% confidence interval of the healthy subjects.

References

    1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006;90:262–267. doi: 10.1136/bjo.2005.081224. - DOI - PMC - PubMed
    1. Quigley HA, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 2000;41:3460–3466. - PubMed
    1. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv. Ophthalmol. 1994;39:23–42. doi: 10.1016/S0039-6257(05)80042-6. - DOI - PubMed
    1. Anderson DR, Hendrickson A. Effect of Intraocular Pressure on Rapid Axoplasmic Transport in Monkey Optic Nerve. Invest. Ophthalmol. Vis. Sci. 1974;13:771–783. - PubMed
    1. Harry Q, Earl A. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 1980;19:137–152. - PubMed

Publication types